Medix Infusion closes on funding 

DALLAS – Medix Infusion has closed a $35 million Series B funding round led by Echo Health Ventures. Additional participants included Pittco Direct Investments II, the direct investing arm of Pittco Management, LLC, and initial investor Noro-Moseley Partners. The company will use its newly secured investment to support organic growth and acquire the infusion operations of the Center for Neurology and Spine, a national leader in the treatment of neurological disorders that serves patients across five infusion suites in Arizona. “We are thankful for the confidence in our company and its vision demonstrated by our new partners, Echo Health Ventures and Pittco, and energized by the continued trust of Noro-Moseley Partners through another round of investment,” said Medix Infusion CEO Gus de Avillez. “Together, we can unlock new strategic opportunities to reduce the overall cost of care and create greater access to convenient, compassionate infusion care in underserved communities across the country.” The Arizona acquisition expands Medix’s geographic footprint into its fifth state with additional operations in Texas, Oregon, Kansas and Missouri. The company simultaneously entered into a debt facility with Live Oak Bank to further support its growth. Medix has experienced 100% year-over-year growth since its inception in April 2020, quickly expanding its network of ambulatory clinics, while continuing to improve the standard of care for infusion patients. It now operates more than 30 locations across five states, along with its home infusion pharmacy operations, impacting the lives of more than 4,600 patients.